Jump to content

Problem:Obstructive sleep apnea in obesity

Unchecked
From Pharmacopedia

This page is early; a full clinical description is coming. The cross-linked medicines below are live.

Moderate-to-severe obstructive sleep apnea in adults with obesity. Basis for the 2024 tirzepatide (Zepbound) OSA approval following SURMOUNT-OSA.

Medicines used for Obstructive sleep apnea in obesity

[edit | edit source]